
Future Therapeutics provides end-to-end drug discovery powered by AI that does not depend on large upfront datasets. The platform centers on Kinetica, integrating AI, physics, systems modeling, and experimental feedback to model transient states in molecules. It targets pharmaceutical and biotech clients with a B2B SaaS-style platform that connects to laboratory workflows and data pipelines. The approach blends machine learning, physics-based simulations, and iterative experiments to accelerate discovery timelines. The solution scales through partnerships across drug classes and research programs, enabling faster candidate identification and optimization.

Future Therapeutics provides end-to-end drug discovery powered by AI that does not depend on large upfront datasets. The platform centers on Kinetica, integrating AI, physics, systems modeling, and experimental feedback to model transient states in molecules. It targets pharmaceutical and biotech clients with a B2B SaaS-style platform that connects to laboratory workflows and data pipelines. The approach blends machine learning, physics-based simulations, and iterative experiments to accelerate discovery timelines. The solution scales through partnerships across drug classes and research programs, enabling faster candidate identification and optimization.